131 related articles for article (PubMed ID: 16821634)
1. HLA-G expression in gastric cancer.
Ishigami S; Natsugoe S; Miyazono F; Nakajo A; Tokuda K; Matsumoto M; Okumura H; Douchi T; Hokita S; Aikou T
Anticancer Res; 2006; 26(3B):2467-72. PubMed ID: 16821634
[TBL] [Abstract][Full Text] [Related]
2. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophage (TAM) infiltration in gastric cancer.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Miyazono F; Hokita S; Aikou T
Anticancer Res; 2003; 23(5A):4079-83. PubMed ID: 14666722
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells.
Du L; Xiao X; Wang C; Zhang X; Zheng N; Wang L; Zhang X; Li W; Wang S; Dong Z
Cancer Sci; 2011 Jul; 102(7):1272-80. PubMed ID: 21466615
[TBL] [Abstract][Full Text] [Related]
5. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
[TBL] [Abstract][Full Text] [Related]
7. HLA-class I expression in gastric cancer.
Ishigami S; Natsugoe S; Nakajo A; Arigami T; Kitazono M; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Aikou T
J Surg Oncol; 2008 Jun; 97(7):605-8. PubMed ID: 18459158
[TBL] [Abstract][Full Text] [Related]
8. Analysis of human lymphocyte antigen class I expression in gastric cancer by reverse transcriptase-polymerase chain reaction.
Dutta N; Majumder D; Gupta A; Mazumder DN; Banerjee S
Hum Immunol; 2005 Feb; 66(2):164-9. PubMed ID: 15695002
[TBL] [Abstract][Full Text] [Related]
9. [HLA-G: a tolerance molecule implicated in the escape of tumors from immunosurveillance].
Paul P; Rouas-Freiss N; Carosella ED
Pathol Biol (Paris); 1999 Oct; 47(8):766-70. PubMed ID: 10573693
[TBL] [Abstract][Full Text] [Related]
10. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.
de Kruijf EM; Sajet A; van Nes JG; Natanov R; Putter H; Smit VT; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
J Immunol; 2010 Dec; 185(12):7452-9. PubMed ID: 21057081
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma: expression of HLA-G.
Adithi M; Kandalam M; Ramkumar HL; Subramanian A; Venkatesan N; Krishnakumar S
Ocul Immunol Inflamm; 2006 Aug; 14(4):207-13. PubMed ID: 16911982
[TBL] [Abstract][Full Text] [Related]
13. The clinical status and histopathological factors affecting natural killer cells of peripheral blood lymphocytes in patients with gastric cancer.
Nio Y; Shiraishi T; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T
J Clin Lab Immunol; 1991 Jul; 35(3):97-108. PubMed ID: 1668768
[TBL] [Abstract][Full Text] [Related]
14. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Lung Cancer; 2007 Nov; 58(2):267-74. PubMed ID: 17673327
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitro.
Sun LL; Han Y; Chen JH; Yao YQ
Fertil Steril; 2008 Dec; 90(6):2398-405. PubMed ID: 18243178
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma.
Hyakudomi M; Matsubara T; Hyakudomi R; Yamamoto T; Kinugasa S; Yamanoi A; Maruyama R; Tanaka T
Ann Surg Oncol; 2008 Jun; 15(6):1775-82. PubMed ID: 18363071
[TBL] [Abstract][Full Text] [Related]
17. [Effect of GrB- positive expression in benign and malignant gastric epithelial tissue on local immune response].
Zhou Y; Shi D
Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):966-9. PubMed ID: 12181090
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma.
Barrier BF; Kendall BS; Sharpe-Timms KL; Kost ER
Gynecol Oncol; 2006 Oct; 103(1):25-30. PubMed ID: 16530254
[TBL] [Abstract][Full Text] [Related]
19. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
[TBL] [Abstract][Full Text] [Related]
20. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
Rouas-Freiss N; Moreau P; Ferrone S; Carosella ED
Cancer Res; 2005 Nov; 65(22):10139-44. PubMed ID: 16287995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
